PP 210Alternative Names: PP-210
Latest Information Update: 19 Dec 2013
At a glance
- Originator Peritech Pharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Genital warts
Most Recent Events
- 17 Dec 2013 Preclinical trials in Genital warts in Israel (unspecified route)